These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9921114)

  • 21. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biopharmaceutic and technological investigation of vagina suppositories containing brilliant green].
    Dzhavakhiia MSh; Churadze LI; Iavich PA
    Georgian Med News; 2008 May; (158):33-6. PubMed ID: 18560037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liberation of water soluble active principles from suppositories. Influence of rheologic properties of utilized fat excipients].
    Moës A
    J Pharm Belg; 1974; 29(1):85-6. PubMed ID: 4831721
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppositories in anal disorders: a review.
    Gupta PJ
    Eur Rev Med Pharmacol Sci; 2007; 11(3):165-70. PubMed ID: 17970232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal suppository insertion: the reliability of the evidence as a basis for nursing practice.
    Bradshaw A; Price L
    J Clin Nurs; 2007 Jan; 16(1):98-103. PubMed ID: 17181671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liberation of active substances from suppository bases. II. In vivo studies of phenobarbital suppositories].
    Grzesiczak A; Ludwicki H; Ostrowska E
    Acta Pol Pharm; 1981; 38(4):493-7. PubMed ID: 7331837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Liberation of the active ingredient from isoprenaline (Izadrin) containing suppositories].
    Buzovszkij A; Regdon G; Regdon G
    Acta Pharm Hung; 1982 Jan; 52(1):33-7. PubMed ID: 7058691
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis.
    Gutiérrez Millán C; Zarzuelo Castañeda A; Sayalero Marinero ML; Lanao JM
    Blood Cells Mol Dis; 2004; 33(2):132-40. PubMed ID: 15315791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of the liberation of active agents from suppositories].
    Regdon G; Kedvessy G
    Acta Pharm Hung; 1968 Jun; 38(2):179-85. PubMed ID: 5723265
    [No Abstract]   [Full Text] [Related]  

  • 30. [The time of complete deformation of suppositories and the capacity of liberation of therapeutic substances as criteria for the evaluation of modern bases. II. In vitro studies on the liberation of substances from fatty bases].
    KROWCZYNSKI L
    Acta Pol Pharm; 1962; 19():127-42. PubMed ID: 14459871
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of diclofenac released from suppositories using UV spectrophotometry, spectra derivative spectrophotometry and HPLC.
    Sznitowska M; Stokrocka M
    Acta Pol Pharm; 2007; 64(5):401-5. PubMed ID: 18540158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The influence of thermal constraints on the liberation of the active principal from the suppository form: the case of acetylsalicylic acid].
    Lasserre Y; Peneva B; Jacob M; Puech A
    J Pharm Belg; 1986; 41(1):12-6. PubMed ID: 3701563
    [No Abstract]   [Full Text] [Related]  

  • 33. Chlorpropamide--a dosage correction.
    Bransome ED
    Hosp Pract; 1979 Jun; 14(6):23-4. PubMed ID: 447325
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin.
    Kosior A
    Acta Pol Pharm; 2002; 59(5):353-8. PubMed ID: 12602796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hydrogels: properties and application in the technology of drug form. II. Possibilities of use of hydrogels as active substance carriers].
    Pluta J; Karolewicz B
    Polim Med; 2004; 34(3):63-81. PubMed ID: 15631157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of partial glycerides on the liberation of aminophenazone from suppositories].
    Bornschein M; Voigt R; Petri U
    Pharmazie; 1978 Sep; 33(9):591-3. PubMed ID: 733873
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current problems in the quality control of pharmaceutical preparations manufactured in pharmacies III. Investigation of theophilline containing suppositories].
    Takácsné NK; Sinkó B; Hang I; Kiss G; Dávid AZ; Horváth PE
    Acta Pharm Hung; 2007; 77(2):82-9. PubMed ID: 17933266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relieving perineal pain after perineorrhaphy by diclofenac rectal suppositories: a randomized double-blinded placebo controlled trial.
    Achariyapota V; Titapant V
    J Med Assoc Thai; 2008 Jun; 91(6):799-804. PubMed ID: 18697376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectal analgesia for the relief of perineal pain after childbirth: a randomised controlled trial of diclofenac suppositories.
    Dodd JM; Hedayati H; Pearce E; Hotham N; Crowther CA
    BJOG; 2004 Oct; 111(10):1059-64. PubMed ID: 15383107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.